Healthpeak Properties - PEAK Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $32.67
  • Forecasted Upside: 42.52 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$22.92
▲ +0.34 (1.51%)

This chart shows the closing price for PEAK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Healthpeak Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PEAK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PEAK

Analyst Price Target is $32.67
▲ +42.52% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Healthpeak Properties in the last 3 months. The average price target is $32.67, with a high forecast of $40.00 and a low forecast of $26.00. The average price target represents a 42.52% upside from the last price of $22.92.

This chart shows the closing price for PEAK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 investment analysts is to hold stock in Healthpeak Properties. This rating has held steady since May 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
4/8/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
7/7/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/5/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
1/3/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 1 sell ratings
4/3/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 1 sell ratings
7/2/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
8/31/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/30/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/28/2022Wolfe ResearchUpgradePeer Perform ➝ Outperform$27.00Low
9/9/2022BarclaysLower TargetOverweight$38.00 ➝ $36.00Low
8/31/2022Morgan StanleyBoost TargetEqual Weight$26.00 ➝ $27.00Low
7/29/2022MizuhoLower TargetNeutral$37.00 ➝ $29.00Low
7/15/2022Morgan StanleyLower TargetEqual Weight$32.50 ➝ $26.00Low
7/8/2022CitigroupUpgradeNeutral ➝ Buy$33.00 ➝ $31.00N/A
6/30/2022Jefferies Financial GroupLower TargetHold$33.00 ➝ $26.00Low
6/20/2022Evercore ISISet Target$32.00Low
6/3/2022Capital One FinancialInitiated CoverageEqual Weight ➝ Equal Weight$34.00Low
6/1/2022Morgan StanleyLower TargetEqual Weight$34.50 ➝ $32.50Low
5/19/2022Bank of AmericaDowngradeBuy ➝ Neutral$32.00Medium
4/4/2022Credit Suisse GroupBoost TargetNeutral$37.00 ➝ $38.00Low
3/7/2022Morgan StanleyLower TargetEqual Weight$35.50 ➝ $34.50Medium
2/1/2022Credit Suisse GroupInitiated CoverageNeutralLow
12/20/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$38.00 ➝ $40.00Low
12/6/2021Wolfe ResearchInitiated CoverageMarket Perform$36.00Low
11/29/2021Morgan StanleyLower TargetEqual Weight$37.00 ➝ $35.50Low
11/18/2021Royal Bank of CanadaBoost TargetOutperform$39.00 ➝ $40.00Low
9/13/2021Morgan StanleyBoost TargetEqual Weight$32.00 ➝ $37.00Low
8/17/2021Royal Bank of CanadaBoost TargetOutperform$36.00 ➝ $39.00Low
7/26/2021Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $32.00Low
7/23/2021Wells Fargo & CompanyBoost TargetUnderweight$32.00 ➝ $36.00Low
7/14/2021MizuhoReiterated RatingNeutral$32.00Low
6/15/2021ArgusBoost TargetBuy$34.00 ➝ $39.00Medium
5/26/2021JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$33.00 ➝ $34.00Medium
5/24/2021Royal Bank of CanadaBoost TargetOutperform$35.00 ➝ $36.00Medium
5/20/2021Berenberg BankUpgradeHold ➝ BuyLow
5/20/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$33.00 ➝ $34.00Low
5/6/2021BarclaysBoost TargetOverweight$33.00 ➝ $36.00Medium
4/14/2021Wells Fargo & CompanyBoost Target$25.00 ➝ $32.00Medium
3/30/2021Bank of AmericaUpgradeNeutral ➝ Buy$34.00 ➝ $35.50Low
3/15/2021Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $30.00Medium
2/9/2021MizuhoBoost TargetNeutral$29.00 ➝ $32.00Low
1/20/2021Capital One FinancialUpgradeEqual Weight ➝ OverweightMedium
12/29/2020BarclaysBoost TargetOverweight$30.00 ➝ $33.00N/A
12/15/2020Smith Barney CitigroupBoost Target$28.00 ➝ $30.00Medium
12/14/2020KeyCorpDowngradeOverweight ➝ Sector WeightLow
12/10/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$26.00 ➝ $25.00High
11/4/2020Raymond JamesReiterated RatingBuyLow
10/16/2020MizuhoDowngradeBuy ➝ Neutral$30.00 ➝ $29.00Medium
9/4/2020BarclaysBoost TargetOverweight$28.00 ➝ $30.00Low
9/1/2020Stifel NicolausInitiated CoverageBuy$31.00High
8/21/2020Morgan StanleyBoost TargetEqual Weight$28.00 ➝ $29.00Low
7/2/2020CitigroupBoost TargetNeutral$24.00 ➝ $28.00Low
7/2/2020Berenberg BankInitiated CoverageHoldLow
5/22/2020BMO Capital MarketsReiterated RatingBuy$30.00Low
5/14/2020Royal Bank of CanadaLower Target$32.00 ➝ $27.00High
4/29/2020Raymond JamesDowngradeOutperform ➝ Market PerformHigh
4/21/2020MizuhoLower TargetBuy$41.00 ➝ $30.00Low
4/21/2020KeyCorpLower TargetOverweight$37.00 ➝ $30.00High
4/14/2020Royal Bank of CanadaReiterated RatingBuy$32.00Low
4/8/2020BarclaysReiterated RatingBuy$28.00High
4/7/2020CitigroupLower TargetNeutral$38.00 ➝ $24.00High
4/3/2020JPMorgan Chase & Co.Lower TargetOverweight$38.00 ➝ $29.00Medium
3/27/2020Wells Fargo & CompanyLower TargetEqual Weight$35.00 ➝ $26.00Medium
3/25/2020Raymond JamesLower TargetOutperform$37.00 ➝ $28.00High
3/23/2020Bank of AmericaDowngradeBuy ➝ NeutralHigh
3/17/2020Morgan StanleyLower TargetEqual Weight$35.00 ➝ $28.00High
3/9/2020Royal Bank of CanadaReiterated RatingBuy$40.00Medium
2/13/2020BMO Capital MarketsReiterated RatingBuy$38.00High
2/12/2020MizuhoReiterated RatingBuy$38.00High
12/19/2019MizuhoInitiated CoverageBuy$39.00High
(Data available from 9/30/2017 forward)

News Sentiment Rating

0.25 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 33 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/4/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/3/2022
  • 1 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/3/2022
  • 3 very positive mentions
  • 34 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
6/2/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/2/2022
  • 1 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/1/2022
  • 3 very positive mentions
  • 34 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/31/2022
  • 1 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/30/2022

Current Sentiment

  • 1 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Read More

Today's Range

Now: $22.92
Low: $22.58
High: $23.10

50 Day Range

MA: $26.43
Low: $22.58
High: $28.37

52 Week Range

Now: $22.92
Low: $22.44
High: $36.85

Volume

8,160,216 shs

Average Volume

4,084,629 shs

Market Capitalization

$12.37 billion

P/E Ratio

55.90

Dividend Yield

5.31%

Beta

0.78

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthpeak Properties?

The following equities research analysts have issued stock ratings on Healthpeak Properties in the last twelve months: Bank of America Co., Barclays PLC, Capital One Financial Co., Citigroup Inc., Credit Suisse Group AG, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Royal Bank of Canada, and Wolfe Research.
View the latest analyst ratings for PEAK.

What is the current price target for Healthpeak Properties?

12 Wall Street analysts have set twelve-month price targets for Healthpeak Properties in the last year. Their average twelve-month price target is $32.67, suggesting a possible upside of 42.5%. JPMorgan Chase & Co. has the highest price target set, predicting PEAK will reach $40.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $26.00 for Healthpeak Properties in the next year.
View the latest price targets for PEAK.

What is the current consensus analyst rating for Healthpeak Properties?

Healthpeak Properties currently has 6 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PEAK, but not buy more shares or sell existing shares.
View the latest ratings for PEAK.

What other companies compete with Healthpeak Properties?

How do I contact Healthpeak Properties' investor relations team?

Healthpeak Properties' physical mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The company's listed phone number is (949) 407-0700 and its investor relations email address is [email protected] The official website for Healthpeak Properties is www.healthpeak.com. Learn More about contacing Healthpeak Properties investor relations.